The sex of animals can be determined by varied cues in different species, including chromosomes, temperature, social status and photoperiod 1 . A common feature of sexual regulation across much of the animal kingdom is the involvement of DMRT proteins 2, 3 . These are transcription factors related to Doublesex (Dsx) and Male abnormal-3 (MAB-3), key sexual regulators of insects and nematodes, respectively, and they share the highly conserved DM DNA-binding domain 4, 5 .
The sex of animals can be determined by varied cues in different species, including chromosomes, temperature, social status and photoperiod 1 . A common feature of sexual regulation across much of the animal kingdom is the involvement of DMRT proteins 2, 3 . These are transcription factors related to Doublesex (Dsx) and Male abnormal-3 (MAB-3), key sexual regulators of insects and nematodes, respectively, and they share the highly conserved DM DNA-binding domain 4, 5 .
Genetic studies have found that DMRT-encoding genes can control the primary sex-determination decision, can act subsequently in sexual differentiation or, in some species, can do both 2 . DMRTencoding genes are required for sexual development in planaria 6 , insects 7 , nematodes 8 and vertebrates 9 , thus suggesting that their involvement in this process spans hundreds of millions of years. Vertebrates have six to seven DMRT-encoding genes, and at least one of these appears to regulate testis development in most or possibly all species, with DMRT1 playing a leading part in the process. In some vertebrate groups, including birds 10, 11 , some fish 12 and amphibians 13 , a DMRT1 ortholog is located on a sex chromosome and has a sex-determining role 2 . In mammals, DMRT1 is crucial for many aspects of testicular development 2 . Deletions of human chromosome 9p that cause DMRT1 hemizygosity result in 46,XY gonadal dysgenesis, which can include sex reversal 14, 15 . In mice, DMRT1 has been shown to regulate gonadal differentiation, and continuous DMRT1 expression is required to maintain the male cell fate of testicular Sertoli cells, by preventing their transdifferentiation to female granulosa cells 16 . Moreover, DMRT1 overexpression in mouse ovaries can cause male sex determination or female-to-male cell-fate transdifferentiation 17, 18 .
DMRT1 appears to be a bifunctional transcription factor, activating or repressing transcription of target genes. We previously found in mice that DMRT1 binds and regulates genes known to have key roles in mammalian sexual development, by activating the central male sex-determining gene Sox9, repressing the female sex-determining genes Wnt4 and Rspo1, and regulating many other genes involved in subsequent sexual differentiation 16 . Here we have combined genomic, molecular, biochemical, structural and human genetics approaches to address how DMRT1 recognizes target-site DNA. We find that DMRT1 uses a unique type of protein-DNA interaction and can also use multiple distinct stoichiometries to discriminate among target sites with distinct DNA sequences. We also show that disrupting conserved residues in the DM domain that make base-specific contacts with DNA can severely reduce binding affinity and cause sex reversal in flies and in humans.
RESULTS
In vivo DMRT1-binding-site determination in mice and humans DMRT1 binds in vitro to a pseudopalindromic 13-bp DNA sequence 19 , but how the DM domain recognizes target DNAs is poorly understood because no composite protein-DNA structure has been described. For a genome-wide view of DMRT1-binding sites on DNA, we first performed chromatin immunoprecipitation and sequencing (ChIP-seq) in testes of adult mice and humans. ChIP-seq identified 8,571 strongly enriched sites in mice and 7,593 in humans. Nine percent of human sites with synteny in mice were bound in both species (example in Fig. 1a) , a result typical for a tissue-specific transcription factor 20, 21 . Motif searches revealed a DNA consensus element associated with in vivo binding in both species, which includes several nearly invariant nucleotides and resembles the in vitro consensus (Fig. 1b) .
To examine binding to the in vitro DNA consensus (site 1), we next mapped DMRT1-DNA interactions by DNase I protection. A truncated DMRT1 protein containing the highly conserved human DM domain, DMRT1 (Supplementary Fig. 1 ), protected the top DNA strand beyond the central 13 bp (Fig. 1c) . Protection was stronger on the left side, which is predicted 22 to have a narrower minor groove (Fig. 1d) . We made base changes to site 1 that are expected to compress the right-side minor groove (site 2; Fig. 1d ), and these resulted in extended protection and reduced electrophoretic mobility shift of full-length DMRT1 protein (Fig. 1c,e) . The altered DNase I protection and electrophoretic mobility of site 2 relative to site 1 together suggest that DMRT1 can bind DNA with multiple stoichiometries or conformations.
DMRT1 inserts paired a-helices into the DNA major groove For a detailed view of the DM-domain structure and insight into how DMRT1 interacts with DNA, we used X-ray crystallography, examining the interaction between the DMRT1 DM domain and site 1. Crystals of DMRT1 (Supplementary Fig. 1 ) and a 25-bp DNA corresponding to site 1 yielded a 3.8-Å-resolution structure ( Table 1) containing three DM-domain protomers bound to a single DNA molecule (protomers A-C; Fig. 2a,b) . The overall resolution of the DMRT1 67-136 -DNA structure is not high; this probably reflects a combination of inherent flexibility of the complex, loose lattice contacts and the crystals' high solvent content and radiation sensitivity. We were able to mitigate these issues by validating the registers of DNA and protein residues, using crystals containing brominated DNA and selenomethionine-substituted protein ( Supplementary Fig. 2 and Table 1 ).
This first view of a DM domain bound to DNA revealed a unique type of DNA interaction. The zinc-binding module of each protomer spans the DNA minor groove, primarily through phosphatebackbone contacts, while a recognition helix inserts into the major groove, making base-specific contacts (Fig. 2a,b) . Unexpectedly, recognition helices of protomers A and B lie antiparallel together in the major groove on one side of the consensus element, while a third (protomer C) lies in the major groove on the other side. We are unaware of any other protein that binds DNA by insertion of two adjacent α-helices into the same region of the major groove.
In the structure, protomers A and B bind DNA differently, reflecting different angles between their zinc-binding modules and recognition helices (Fig. 2c) . Major-groove contacts on the left side of the binding site involve three amino acids (R111, V119 and R123) provided by protomers A and B (Fig. 2d,f) . By contrast, although major-groove contacts on the right side also involve these same three amino acids, all are provided by protomer C (Fig. 2d,g,i) . The leftside major groove is unusually wide (Fig. 1d) , and it accommodates protomers A and B, which sit more perpendicular to the helical axis A r t i c l e s than protomer C (Fig. 2d,e) . In protomers B and C, R72, N terminal to the zinc-binding module, inserts into the minor groove to hydrogen-bond with base pairs (Fig. 2d,f-h) ; these interactions are consistent with use of arginine by other proteins to mediate minorgroove contacts 23 . The hydrogen-bond donor-acceptor pattern is almost indistinguishable in the minor groove for A-T versus T-A, and G-C versus C-G base pairs 24, 25 . Thus, base readout by R72 probably involves base-pair recognition rather than base recognition and may also involve shape readout 25 . All three DMRT1 protomers extensively contact the DNA backbone (Fig. 3a) . They also interact with each other: the recognition helices of protomers A and B are held in close apposition by an interdigitating hydrophobic zipper, and protomers B and C are hydrogen-bonded (Fig. 3b,c) . The overall folding pattern of the zinc-binding module is very similar to that of Dsx (Fig. 3d) , previously determined by NMR 26 . Critical DM-domain amino acids and protein-DNA and protein-protein contacts are summarized in Figure 3e ,f. The contacts shown can explain virtually all of the conserved DM-domain amino acids and DNA nucleotides in the binding site (Fig. 3f) . Most conserved amino acids without functions indicated have structural roles in maintaining the overall structure of the DM domain, for example by terminating helical domains, allowing bending or mediating folding of the zinc-binding module 26 .
Sequence-specific binding is primarily via the DNA major groove A prior study 26 found that DM-domain DNA binding tolerates extensive chemical modification of the DNA major groove but not the minor groove, and it proposed on this basis that binding is mainly mediated by sequence-specific minor-groove contacts. However, minor-groove contacts can distinguish only A-T from G-C base pairs but cannot distinguish specific sequences. Indeed, although our structure revealed potential hydrogen-bond interactions of R72 with the minor groove, the positions contacted by R72 do not show strong sequence conservation. By contrast, the structure revealed extensive sequence-specific major-groove interactions. These interactions involved highly conserved DNA base pairs (−6 and +6; −2 and +2) that were not specifically tested in the previous study. To verify the importance of these base pairs, we first changed the −6 and +6 positions from dG-dC to dA-dT (Fig. 4a) , and this strongly reduced DMRT1 binding (Fig. 4b) . To query the minor groove at these positions, we substituted dI-dC base pairs, removing minor-groove exocyclic amines without altering the major groove (Fig. 4a) ; these substitutions did not reduce binding (Fig. 4b) . To query the major groove, we substituted 2-aminopurine (2AP)-dU base pairs, inverting the carbonyl oxygen and removing the exocyclic amine from the major groove without altering the minor-groove structure (Fig. 4a) . 2AP-dU substitution virtually eliminated DMRT1 binding, thus demonstrating the importance of the major-groove sequence identity at these positions (Fig. 4b) . The same major-groove modifications at the −2 and +2 positions also reduced binding, but minorgroove modifications at these positions did not (Fig. 4c) . In summary, the −6 and +6 and the −2 and +2 positions are crucial for DNA binding, and these positions are recognized primarily via the major groove.
We also used protein-sequence substitutions to assess the importance of amino acid side chains that make major-or minorgroove contacts. Replacing R72, R111, V119 or R123 with alanine reduced or eliminated DMRT1 binding, results indicating that these residues are crucial for DNA recognition ( Fig. 4d and Supplementary  Fig. 3 ). DNA-backbone contacts also are important for DMRT1's DNA binding affinity, because K92A reduced binding ( Fig. 4e and Supplementary Fig. 3a ). These functional analyses were particularly important given the limited resolution of the X-ray structure.
DMRT1 can bind DNA as a tetramer, trimer or dimer
Next, we further examined DNA binding stoichiometry. The structure showed that site 1 can bind a DMRT1 trimer, and DNase I protection showed that site 2 is more extensively protected by DMRT1 than site 1. These data suggest that the slower-migrating electrophoretic mobility shift analysis (EMSA) complex on site 2 (Figs. 1e and 5a) is a symmetric ABB′A′ tetramer. Site 2 differs from site 1 at +5, a position that is uniquely recognized by protomer C (Figs. 2d) , and it also has changes at +8 and +9 that are predicted to narrow the minor groove between +6 and +8 (Fig. 1d) . These differences suggest that DNA sequence and shape may dictate protein binding mode. We hypothesized that making other structure-guided sequence changes to site 1 might instead cause AB dimers to form. Indeed, modifying site 1 at +2 and +6 to alter bases recognized specifically by protomer C (site 3) generated a faster-migrating EMSA complex consistent with an AB dimer ( Fig. 5a and Supplementary Fig. 3b ). To confirm that DMRT1 can bind DNA with multiple stoichiometries, we performed additional EMSAs. Instead of full-length DMRT1 (as in Fig. 5a ), we used DMRT1 67-136 , which removes a multimerization domain (not shown) and reduces cooperative binding. DMRT1 67-136 A r t i c l e s formed three distinct complexes with site 1 (Fig. 5b) , which we interpret as monomers, dimers and trimers. Because binding to site 2 was highly cooperative even with DMRT1 67-136 , we also assayed a site with reduced affinity and cooperativity (site 4). On site 4, DMRT1 67-136 formed four complexes ( Fig. 5b) , which we interpret as monomer through tetramer. To further confirm these stoichiometries, we performed protein cross-linking, using full-length DMRT1 bound to sites 1-3 ( Fig. 5c ). As predicted, DMRT1 formed DNA-dependent complexes of different maximum stoichiometries. Dimers formed on site 3; dimers and trimers formed on site 1, with traces of tetramer; and dimers, trimers and tetramers formed on site 2. Together, the structure, DNase I protection, EMSA analyses and protein cross-linking indicate that DMRT1 can bind DNA in vitro as a tetramer, a trimer or a dimer and, when the protein is truncated, as a monomer.
We next asked whether DMRT1 also binds DNA by using multiple stoichiometries in vivo. For a higher-resolution view of DMRT1-DNA interaction in vivo we used ChIP-exo 27 , which uses strand-specific exonuclease digestion before sequencing to localize protein-DNA crosslinks with higher precision than ChIP-seq. ChIP-exo did not reveal exact binding details at individual sites, so we used structural and in vitro DNA binding properties to group sites ( Fig. 5d) and reveal their patterns of binding, a strategy that has also been used with other proteins 28 . We searched the genome for matches to the 7-bp core DMRT1 binding motif and selected those found under DMRT1 ChIP peaks. We then used minor-groove width predictions 29 to group peaks into those predicted to have bilateral narrowing of the minor groove (tetramers) and those with unilateral narrowing (dimers and trimers). Guided by the structure and EMSA analysis, we further selected sites on the basis of the sequence at positions −6, +5 and +6 (Fig. 5d) . Finally, we A r t i c l e s plotted the ChIP-exo data in aggregate for each set of DMRT1-binding sites and compared the binding patterns, asking whether they differed and whether their differences were consistent with binding by each of the stoichiometries identified in vitro (Fig. 5e,f) . Comparison of the compiled ChIP-exo data revealed a shared pattern on the left side in all three classes, as expected, but distinct patterns on the right. The predicted cross-linking patterns for each binding mode, according to the structure, conform well to the observed cross-linking patterns for the different groups of sites ( Fig. 5f and Supplementary Fig. 4a ).
Predicted tetramers had symmetrical ChIP-exo patterns, whereas those of trimers and dimers were asymmetric, as expected. In trimers, the protomer C recognition helix sits at an angle in the DNA major groove that allows juxtaposition with more bases than in protomers A and B (Fig. 2d,e ) and therefore has a higher density of potential cross-links ( Fig. 5f and Supplementary Fig. 4b) ; consistently with this prediction, we observed stronger cross-links on the right side of the binding site, where protomer C would bind. Compilation of the selected DMRT1 consensus sequences did not reveal additional sequence or shape preferences, thus suggesting that the primary determinant of stoichiometry is the sequence and shape at the DMRT1-binding site rather than the presence of additional motifs ( Supplementary  Fig. 4c,d ). Distinct patterns also were apparent in standard ChIP-seq, at lower resolution (Supplementary Fig. 4a ). In summary, ChIP-exo suggests that DMRT1 binds as a tetramer, trimer or dimer in vivo, as in vitro, with the mode at each site determined by a combination of DNA sequence and shape. 71  74  73  72  75  76  77  78  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  94  95  96  97  98  99  100  101  102  103  104  105  106  107  018  109  110  111  112  113  114  115  116  117  118  119  120  121  122  123  124  125  126  127  128  129 
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Modeling suggests related binding modes for Dsx and MAB-3
Related but different DNA binding modes are probably used by the invertebrate sexual regulators Dsx and MAB-3. In vitro, Dsx and DMRT1 bind similar motifs, but Dsx has no sequence preference at −6 and +6 (Fig. 6a) . EMSA confirmed that the −2 and +2 positions are important for binding of both Dsx and DMRT1, but −6 and +6 are important only for DMRT1 binding (Fig. 6b) . This requirement for only the inner core of the binding motif suggests that Dsx binds as a symmetrical BB′-like dimer (modeled in Fig. 6c) . Caenorhabditis elegans MAB-3 has tandem DM domains (Supplementary Fig. 5 ) and binds a site reminiscent of a DMRT1 half-site 30 (Fig. 6a) . Molecular modeling suggests that the MAB-3 tandem DM domains might be equivalent to a DMRT1 AB dimer, with the truncated first recognition helix allowing looping so that both helices can bind adjacent to each other in the major groove (Fig. 6d) . 7 , and a number of dsx point mutations have been isolated that cause an intersex phenotype in Drosophila 5 . Most of these mutations alter residues required for zinc chelation, but one, R91Q, affects a recognition-helix residue equivalent to R123 in DMRT1 (Supplementary Fig. 5 ) and reduces DSX DNA binding 5 . We tested DMRT1 R123Q by EMSA and found that, like DMRT1 R123A (Fig. 4a) , it eliminated DNA binding ( Fig. 7a and Supplementary  Fig. 3c ). This result suggests that the Dsx R91Q mutation disrupts a highly conserved sex-determining contact.
DM-domain point mutations affect DNA binding in fly and human sex reversal dsx determines sex in insects
As discussed earlier, DMRT1 determines gonadal sex in some vertebrates 2 , but its role in human testis development has been less clear. In humans, primary XY male-to-female sex reversal results in female external genitalia and Mullerian structures (uterus and fallopian tubes) and undeveloped ('streak') gonads. This condition is also called 46,XY complete gonadal dysgenesis, or 46,XY CGD 31 . Human genetics has implicated DMRT1 as a key regulator of testis development: chromosome 9p deletions that remove one copy of DMRT1 are associated with 46,XY feminization and gonadal dysgenesis, sometimes including 46,XY CGD 15, 32 . Although they suggest that DMRT1 is haploinsufficient for testicular development, these deletions usually remove other genes, including the neighboring DMRT2 and DMRT3. Also, most 9p deletions cause incomplete gonadal dysgenesis, so it has been unclear whether hemizygosity of DMRT1 alone can cause full sex reversal. Although a DMRT1 deletion removing exons 3 and 4, downstream of the DM domain, was found in a strongly feminized 46,XY individual 32 , this deletion could have removed regulatory elements that affect other genes. Point mutations would help determine whether loss of DMRT1 alone can cause sex reversal, but these have not been reported.
We therefore used exome resequencing to seek a DMRT1 point mutation. We were able to identify a 46,XY individual born fully feminized with complete gonadal dysgenesis (46,XY CGD) and carrying a heterozygous de novo point mutation (R111G) in the DMRT1 recognition helix (Fig. 7b, Supplementary Fig. 5a and Online Methods). Genetic analysis found normal ploidy, and fluorescence in situ hybridization confirmed two copies of the regions containing DMRT1 as well as the sex-determining genes NR5A1, SOX9, WT1 and DAX1 (official symbol NR0B1). No other potentially pathogenic mutations were apparent in the exome sequence, and the DMRT1 mutation was not present in 240 ancestry-matched control individuals. Full details of the clinical and genetic characterization of this subject are provided in Online Methods. We conclude that the de novo DMRT1 R111G mutation is the most likely cause of the complete gonadal dysgenesis and 46,XY sex reversal in this subject. To our knowledge, this is the first human DMRT1 point mutation associated with 46,XY sex reversal. The phenotype is very similar to that caused by mutations in the testis-determining gene SRY 33 , and it strongly suggests that DMRT1 is required for human sex determination.
We next examined the DNA binding properties of DMRT1 R111G and found that the mutant protein had strongly reduced DNA affinity, similar to DMRT1 R111A (Figs. 7a and 4d and Supplementary Fig. 3a,c) . In the structure, R111 of protomer C interacts with the +5 and +6 positions of site 1 (Fig. 7g) . We found that DMRT1 R111G had altered sequence specificity: it bound a site with −6 and +6 dG-dC to dA-dT substitutions weakly but better than wild-type DMRT1 (Fig. 7c) . Moreover, in an EMSA assay, when mixed with wild-type DMRT1, the mutant protein could promote tetramer binding on site 1, which normally is bound by trimers of wild-type DMRT1 (Fig. 7d) . We also tested binding of DMRT1 R111G to in vivo DMRT1-binding sites from the Sox9 gene (activated by DMRT1) and the Foxl2 gene (repressed by DMRT1) 16, 17 . The Sox9 site is bound as a trimer by wild-type protein (Fig. 7e) . DMRT1 R111G bound this site very weakly, but, when mixed with wild-type protein, it shifted the complex to a tetramer with much higher affinity. The Foxl2 site was bound as a tetramer by wild-type A r t i c l e s DMRT1, and addition of DMRT1 R111G had little or no effect on binding (Supplementary Fig. 6 ). From the ability of DMRT1 R111G to alter binding stoichiometry of wild-type DMRT1 on a biologically relevant site in vitro, we suggest that the DMRT1 R111G mutation may combine severe loss of function and/or haploinsufficiency with a dominant disruption of normal binding stoichiometry at some DMRT1-binding sites. This combination of haploinsufficiency and dominant disruption may explain the severe phenotype caused by DMRT1 R111G heterozygosity. In the structure, R111 of protomer A is positioned to contact −6 by its own M115 and by M115 and Q118 of protomer B (Fig. 7f,h) . We found that mutating these residues also reduced DNA binding (Fig. 7a) . In summary, the severe effects of the DMRT1 R111G point mutation on DNA binding and its association with 46,XY male-to-female sex reversal strongly suggest that DMRT1 has a role in human primary sex determination and identify another deeply conserved molecular interaction crucial for metazoan sexual development.
DISCUSSION
We have undertaken a structural analysis of DMRT protein-DNA interaction. We used ChIP-seq to define the DNA binding preference of DMRT1 in mice and humans and then used X-ray crystallography to determine a DMRT1-DNA structure. The structure revealed that binding of the human DMRT1 DM domain to DNA involves the recognition of specific bases primarily in the DNA major groove. We confirmed this finding by using chemical substitutions that selectively altered the major or minor groove of the DNA at key base pairs. A previous report concluded, on the basis of DNA substitutions, that Dsx binds DNA primarily via the minor groove 26 . From our structural analysis, it is apparent that the minor-groove modifications that reduced binding probably limited the ability of the major groove to expand and accommodate the DM-domain recognition helix rather than affecting sequence-specific base contacts; thus, the previous data are in accord with our structure. 
A r t i c l e s
Binding of DMRT1 to DNA has two particularly noteworthy features. First, binding involves the insertion of paired recognition helices together into a widened DNA major groove. To our knowledge, this is the only example of two closely neighboring α-helices inserting into the same section of a major groove. Second, DMRT1 can bind DNA by using different stoichiometries. The basis of this versatility is that binding involves a small number of amino acid side chains that can make distinct sets of DNA interactions. As a result, different DNA sites can bind distinct configurations of protomers, ranging from dimers to tetramers. ChIP-exo analysis suggests that DMRT1 also binds in vivo with differing stoichiometries. Our ability to predict stoichiometry on the basis of DNA sequence preference and conformation (Fig. 5) suggests that the stoichiometry at a specific 
Site 12 kb 3′ of Sox9 TSS A r t i c l e s 34 . Distinguishing among these possibilities is an important goal, but this will require cell type-specific approaches, because DMRT1 has cell type-specific functions in germ cells and Sertoli cells. Although a number of deletions removing part or all of DMRT1 have been found in people with 46,XY sex reversal, the DMRT1 R111G mutation that we report here is, to our knowledge, the only DMRT1 mutation shown to affect an essential functional domain. The severely reduced DNA binding affinity of DMRT1 R111G combined with the complete sex reversal and gonadal dysgenesis of the subject suggest that DMRT1 plays a part in human sex determination. Our finding that the mutant protein can interfere with the binding stoichiometry of wild-type DMRT1 further suggests that the mutant protein may behave at least partially as a dominant negative. A dominant effect of DMRT1 R111G may help explain why the phenotype of this point mutation is more severe than those of most 9p deletions that completely remove DMRT1. The highly specific nature of point mutations such as DMRT1 R111G that can alter function of the remaining wild-type allele also may explain why DMRT1 point mutations able to cause sex reversal are so rare. Because we observed reduced DNA binding specificity, we cannot exclude the possibility that DMRT1 R111G also binds and misregulates genes that are not normally controlled by DMRT1. An animal model of the DMRT1 R111G may help elucidate the in vivo effects of this mutation.
In summary, we have obtained a detailed view of how DMRT proteins recognize and associate with target DNA. We have defined crucial conserved atomic interactions that mediate DNA binding and found that these are required for sex determination in flies and humans. DMRT proteins have directed metazoan sexual differentiation for hundreds of millions of years 2, 3 . Reproduction is the crucible of natural selection 35 , and the long-term involvement of DMRT genes in sexual development suggests that they have substantially shaped metazoan evolution.
METHODS
Methods and any associated references are available in the online version of the paper. ChIP and ChIP-exo. Chromatin immunoprecipitation (ChIP) was performed as previously described 34 except that tissue was disaggregated with a Virtis Virtishear homogenizer (225318) in phosphate-buffered saline (PBS) containing 1% paraformaldehyde. Sonication times were extended to allow for smaller average-size products suitable for Illumina sequencing. Cross-links were reversed overnight at 55 °C. Illumina sequencing libraries were prepared according to the manufacturer's protocol except that end polishing of the ChIP fragments was by DNA terminator (Lucigen), and adapters were diluted 1:50 before ligation. For ChIP-exo, chromatin precipitation was performed as above and before elution of complexes from protein A-Sepharose beads. ChIP-exo libraries were prepared as previously described 27 except that primer sequences were modified to be compatible with the Illumina sequencing platform.
Primers for ChIP-exo library preparation are as follows: P2 adaptor, 5′-P-aca ctctttccctacacgacgctcttccgatct-3′ annealed to 5′-agatcggaagagcgtcgtgtag-3′. Primer extension oligonucleotide, acactctttccctacacgac. P1 adaptor, gtgactggagt tcagacgtgtgctcttccgatct annealed to agatcggaagagcacacgtctg. PCR amplification was performed with primers P1 and P2 P1, caagcagaagacggcatacgagatcgtgatgt gactggagttcagacgtgtgc. P2, aatgatacggcgaccaccgagatctacactctttccctacacgacgc. Bold text in P1 indicates the sequence that was varied for multiplexing.
Human tissue for ChIP. Fresh testicular tissue from an orchiectomy was provided by the University of Minnesota Tissue Procurement Facility under IRB supervision and with informed consent. Normal histology of Bouin's fixed subsamples was confirmed by hematoxylin/eosin staining of paraffin-embedded sections.
DNA binding substrates. EMSAs to assay stoichiometry of DMRT1 binding used shorter (27-base pair) DNA duplexes for better-resolution of complexes. Sequences are as follows: site 1, top strand, 5′-gagatttgatacattgttgctcgatgg-3′. Site 2, top strand, 5′-gagatttgatacattgttactttatgg-3′. Site 3, top strand, 5′-gagatttgatacattattaatttatgg-3′. Site 4, top strand, 5′-ttgctatgatacattgtatcttgctgg-3′. Sox9 site, top strand, 5′-gtggctgggcaccctgcagagacaatgtttccagctgcaggtcaggtct-3′. Foxl2 site, top strand, 5′-gtggctgggcacaactctgtaacattgtttccaaggggaggtcaggtct-3′.
EMSA to evaluate effects of mutant DNA and protein on binding used longer (49-base pair) DNA duplexes based on the site 1 DNA duplex: 5′-GTGGCTGGG CAgagatttgatacattgttgctcgatggAGGTCAGGTCT-3′. Mutations were incorporated into hDMRT1 by overlap-extension PCR 38 with a T7-hDMRT1 (pDZ142) plasmid clone as template. The mutated products were subcloned back into pDZ142 and translated in vitro with the TNT Quick Coupled transcription/translation system (Promega).
In vitro DNA binding. EMSA was performed as previously described 19 except that substrates were end labeled with T4 polynucleotide kinase (NEB). DNase I footprint analysis was performed with highly purified bacterially expressed hDMRT1 67-136 protein as previously described 39 except that after the DNase I-digestion step, the sample was phenol/chloroform extracted to remove protein before precipitation.
